Search Login Register
Cladribine
Summary
Description:
An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.
Also Known As:
2'-Deoxy-2-chloroadenosine; Leustatin; 2-Chloro-2'-deoxyadenosine; 2-Chlorodeoxyadenosine; Adenosine, 2-chloro-2'-deoxy-
Networked: 839
relevant articles (137 outcomes,
144 trials/studies)
for this Drug
Key Diseases for which Cladribine is
Relevant
-
Hairy Cell Leukemia
:
42 outcomes 15 studies in 226 results
-
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
:
22 outcomes 33 studies in 139 results
-
Non-Hodgkin Lymphoma (Lymphosarcoma)
:
12 outcomes 14 studies in 54 results
-
Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
:
11 outcomes 7 studies in 37 results
-
Lymphoma (Lymphomas)
:
9 outcomes 8 studies in 39 results
Show All >>
Drugs Related to Cladribine
-
purine
-
Cladribine
-
fludarabine
-
rituximab (Mabthera)
-
Pentostatin (Nipent)
-
Cyclophosphamide (Cytoxan)
-
Cytarabine (Cytosar-U)
-
Chlorambucil (Leukeran)
-
Mitoxantrone (Novantrone)
-
2-chloro-3'-deoxyadenosine
Show All >>
Therapies Related to Cladribine
-
Drug Therapy (Chemotherapy)
-
Aftercare (After-Treatment)
-
Intravenous Infusions
-
Salvage Therapy
-
Splenectomy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.